Brief: Plx Pharma Posts Q1 Adjusted Loss Per Share $0.66
13/05/2022 12:43
May 13 (Reuters) - PLx Pharma Inc PLXP.O :
* . REPORTS FIRST QUARTER 2022 RESULTS AND PROVIDES BUSINESS
UPDATE
* Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.66
* Q1 GAAP LOSS PER SHARE $0.39
* Q1 SALES $2.1 MILLION
* CASH & CASH EQUIVALENT BALANCE OF $52.5 MILLION AS OF
MARCH 31,
2022
Source text for Eikon: ID:nGNX1k184T
Further company coverage: PLXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice